查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1137332

安瓿包裝市場 - COVID-19 的增長、趨勢、影響和預測（2022-2027 年）

Ampoules Packaging Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

安瓿包裝市場在2021年達到41億美元，到2027年達到62.7億美元，在預測期內（2022-2027年）的複合年增長率為7.4%。

包裝被認為是製造過程中的關鍵階段，增值過程是主要趨勢之一。長期以來，製藥行業一直使用安瓿瓶，尤其是玻璃瓶作為主要包裝解決方案。

主要亮點

  • 政府大力推廣仿製藥、政府支持設立仿製藥分銷商、該地區傳染病高發等，將導致該地區注射仿製藥的增長。預測期。這些是預計會提振市場的一些因素。
  • 塑料安瓿的出現是為了解決安瓿破裂時玻璃顆粒進入內容物的擔憂。預計這將為塑料安瓿製造商創造機會，並可能受到各國監管升級和標準的影響。
  • 安瓿瓶的使用在很大程度上受到製藥和生命科學最終用戶需求的影響，隨著需求的變化，市場向這些最終用戶傾斜。
  • 負責監督疫苗質量和安全的監管和諮詢機構、發達國家和新興國家的政府、聯合採購機構等都是推動全球疫苗市場需求的關鍵實體。因此，預計近期安瓿產能將獲得動力。
  • 在亞太地區，印度等新興國家的醫藥市場經歷了非凡的增長，SGD Pharma India Ltd. 等公司生產了 4,000 噸管瓶和安瓿瓶（相當於 700 多個SGD Pharma（印度）Vemula 玻璃工廠的百萬台），預計市場將顯著增長。
  • 同樣，安瓿瓶製造商也在進行大量資本投資以在市場上站穩腳跟。例如，Shot AI 將投資 50 卡路裡，建立 3.6 億安瓿的生產能力。
  • 由於全球生產延遲，COVID-19 的傳播最初導致供應鏈中斷，從而對市場產生了負面影響。然而，這種情況發生了很大變化。例如，FEVE（歐洲玻璃容器和機械玻璃製造商聯合會）敦促當局認識到容器玻璃生產的重要作用，隨後領導所有工廠繼續生產，為人們提供食品、飲料和藥品。

主要市場趨勢

塑料安瓿包裝佔很大份額

  • 製藥行業對塑料安瓿的需求正在迅速增長。耐濕性、高尺寸穩定性、高衝擊強度、抗變形、低吸水性、透明度、耐熱性和阻燃性以及延長的保質期是其在製藥行業採用的決定性因素。此外，對低成本封裝的高需求也是該行業的主要推動力。
  • 玻璃容器的特點是易碎，我們知道人們擔心藥物與容器之間的相互作用。這些存儲限制正在推動人們對塑料安瓿的興趣，這些安瓿可以安全地填充、運輸、存儲和有效劑量，同時符合嚴格的監管標準。
  • 隨著液體配方的增加，對塑料包裝的需求也在增加。它們通常是需要極端保護免受外來干擾的優質產品的首選。
  • 液體/半固體給藥方式廣泛應用於有不同用藥需求的兒童。兒童可能難以吞嚥片劑和膠囊，因此他們可能需要較小的劑量。近年來，確保以適合兒童給藥的形式獲得藥物的壓力越來越大。
  • 另一方面，與多劑量包裝相比，單劑量注射包裝越來越成為消費者的選擇。塑料安瓿瓶可實現計量劑量，幫助製藥公司減少藥物過量填充和製造過程效率低下，幫助控製成本。因此，塑料安瓿的使用對於處理昂貴藥品的公司特別有利。
  • 例如，根據食品和藥物管理局 (FDA) 的規定，在美國，單位劑量塑料安瓿瓶佔藥品包裝的近 24%。預計該行業將為安瓿包裝提供高於平均水平的增長機會。

拉丁美洲有望實現顯著的長期增長

  • 在拉丁美洲，各國正在積極努力減少向消費者提供的假冒藥品、疫苗和藥品，從而影響市場的增長。
  • 例如，巴西是該地區最重要的醫藥市場之一，預計將成為全球重要的參與者。巴西醫藥市場目前是世界第 6 大市場，預計到 2022 年底將成為世界第 5 大市場。
  • 同樣，墨西哥在全球醫藥市場排名第 11 位。另一方面，阿根廷被認為是該地區的第三大市場。這些醫藥行業的未來充滿希望的國家，對安瓿來說代表著巨大的機遇。
  • 此外，拉丁美洲的老年人口正在迅速增長。 Pharmaphorum 的數據顯示，2010 年，該地區 10% 的人口年齡在 60 歲以上，到 2040 年底，這一數字預計將增加一倍以上，達到 21%。超過 80% 的 60 歲以上成年人至少患有一種慢性病，這使得慢性病成為導致人口老齡化的主要原因。

競爭格局

安瓿包裝市場是分散的。越來越多的政府舉措以及對注射劑和其他藥品的需求不斷增長，正在為安瓿包裝市場創造有利可圖的機會。總體而言，現有競爭對手之間的競爭非常激烈。未來，各醫藥行業大公司的擴張兼併，有望拉動安瓿包裝的需求。主要參與者包括 Schott AG、Amposan SA 和 Gerresheimer AG。

  • 2021 年 8 月 - 印度血清研究所，最大的疫苗製造商和生物製劑製造商，購買了印度包裝合資企業 SCHOTT Kaisha 50% 的股份。它是德國特種玻璃公司 SCHOTT AG 和印度集團 Kaisha 的合資企業，生產用於包裝救生藥物的藥瓶、注射器、安瓿和藥筒等醫藥包裝產品。
  • 2021 年 5 月 - 日本包裝公司 Nipro Pharma Packaging 收購了克羅地亞玻璃藥品包裝製造商 Piramida。在藍海資本私募股權基金的所有下，Piramida 對其設施進行了現代化改造，安裝了 8 條新的生產線，並見證了其安瓿和西林瓶業務的強勁發展。因此，該公司躋身歐洲市場製藥行業前五名的安瓿製造商之列。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法

第 3 章執行摘要

第 4 章市場動態

  • 市場概覽
  • 工業吸引力 - 波特五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 市場驅動力
    • 藥品包裝防篡改要求
    • 提高可回收玻璃的商業價值
    • 政府法規和標準
  • 市場製約因素
    • 關於傾倒用過的安瓿瓶的擔憂
  • COVID-19 對安瓿包裝市場的影響

第五章市場動態

  • 市場驅動因素和市場製約因素介紹
  • 市場驅動力
    • 藥品包裝防篡改需求
    • 政府法規和標準
  • 市場製約因素
    • 關於傾倒用過的安瓿瓶的擔憂

第 6 章市場細分

  • 按材料
    • 玻璃
    • 塑料
  • 按最終用戶行業
    • 藥品
    • 個人護理、化妝品
    • 其他最終用戶行業
  • 按地區
  • 北美
    • 最終用戶
      • 藥品
      • 個人護理、化妝品
      • 其他最終用戶行業
    • 國名
      • 美國
      • 加拿大
  • 歐洲
    • 最終用戶
      • 藥品
      • 個人護理、化妝品
      • 其他最終用戶行業
    • 國名
      • 英國
      • 法國
      • 德國
      • 其他歐洲地區
  • 亞太地區
    • 最終用戶
      • 藥品
      • 個人護理、化妝品
      • 其他最終用戶行業
    • 國名
      • 中國
      • 印度
      • 日本
      • 其他亞太地區
  • 拉丁美洲
    • 最終用戶
      • 藥品
      • 個人護理、化妝品
      • 其他最終用戶行業
    • 國名
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區
  • 中東和非洲
    • 最終用戶
      • 藥品
      • 個人護理、化妝品
      • 其他最終用戶行業
    • 國名
      • 沙特阿拉伯
      • 埃及
      • 其他中東和非洲

第 7 章競爭格局

  • 公司簡介
    • Schott AG
    • Gerresheimer AG
    • Stevanato Group
    • ESSCO Glass
    • AAPL Solutions
    • Global Pharmatech Pvt Ltd
    • James
    • Alexander Corporation
    • Nipro Pharma Packaging International NV

第八章投資分析

第 9 章市場潛力

簡介目錄
Product Code: 51029

The ampoules packaging market was valued at USD 4.1 billion in 2021, and it is expected to reach a value of USD 6.27 billion by 2027 at a CAGR of 7.4%, during the forecast period (2022-2027). Packaging is considered to be a critical stage in the manufacturing process, where the value addition process is one of the significant trends. The pharmaceutical industry has been using ampoules, especially glass, for a very long period, as a primary packaging solution.

Key Highlights

  • The surge in government initiatives to increase the adoption of generic products, government support to start a generic medical store, and a high prevalence of infectious diseases in the region are some factors that are anticipated to boost the generic injectables market in the region, during the forecast period.
  • The emergence of plastic ampoules in the market has been to counter some of the concerns relating to glass particles entering the contents, during the breaking of the ampoules. This is expected to create an opportunity for plastic ampoules manufacturers and may be impacted by regulatory upgrades and standards present in the respective nation.
  • Since the usage of ampoules is profoundly impacted by its demand in the pharmaceutical and life sciences end users, the market remains highly inclined toward these end-users for demand variations.
  • Regulatory and advisory bodies overseeing vaccine quality and safety, governments across industrialized and developing countries, and pooled procurement agencies are some of the leading entities driving the demand for the vaccine market across the world. This is expected to give a boost to ampoule production capacity in the near term.
  • Asia-Pacific may witness significant growth in the market, as developing countries, such as India, witness exceptional growth in a pharmaceutical market where players, like SGD Pharma India Ltd., produces 4,000 metric ton of tubular vials and ampoules annually (corresponding to more than 700 million pieces at the Vemula glassworks of SGD Pharma (India)) to meet the demand for the ampoules in the market.
  • Likewise, manufacturers of ampoules are significantly investing in the capacity to expand their foothold in the market. For instance, Schott AG Kaisha planned to invest INR 50 crores in the plant, to set up a production capacity of 360 million ampoules.
  • The spread of COVID-19 has negatively impacted the market, due to disruptions in the supply chain initially as a result of delayed production, globally. However, the scenario changed significantly. For instance, FEVE (Federation of European manufacturers of glass containers and machine-made glass) called on the authorities to recognize the critical role of container glass manufacturing and subsequently led the manufacturing continuity across all plants to supply people with food, beverages, and pharmaceutical goods.

Key Market Trends

Plastic Ampoules Packaging to Hold a Significant Share

  • Demand for plastic ampoules is witnessing significant growth from the pharmaceutical industry, Features that led to increased pharmaceutical adoption are barrier against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, resistance to heat and flame, and extension of expiry dates.​ Moreover, the high demand for low-cost packaging is another significant driver to the same.
  • Glass containers are characteristically fragile and have been found to cause concerns involving the drug and container interaction. These storage limitations have led to the growing interest in plastic ampoules that can be effectively filled, shipped, stored, and administered safely while following strict regulatory standards.
  • With an increase in liquid dosage forms, the need for plastic packaging is on the rise. These are often the preferred choice for premium products that require extreme protection from foreign particle interference.
  • Liquid/semisolid drug dosages are widely used for children for different medication needs. Children need smaller doses due to difficulty in swallowing tablets or capsules. Over the last few years, there has been increasing pressure to ensure that drugs are available in the form which is suitable for administration to children.​
  • On the other hand, unit dose parenteral packaging as a choice for consumers over multi-dose packaging has been increasing. Plastic ampoules offer fixed dosages that help pharmaceutical companies control costs by reducing drug overfill and inefficiencies in the manufacturing process. Therefore, the use of plastic ampoules is particularly advantageous for companies dealing with costly drugs.
  • For instance, in the United States, as per the Food and Drug Administration (FDA) regulations, unit dose plastic ampoules account for almost 24% for pharmaceutical packaging. The segment is expected to generate above-average growth opportunities to ampoule packaging.

Latin America To Show Significant Growth Over Long Term

  • In Latin America, the market growth is impacted, as the countries are proactively working to reduce these counterfeit medicine, vaccines, and drugs from reaching the consumers.
  • Brazil, for instance, is among the most prominent pharmaceutical markets in the region, with projections estimating it to emerge as a significant player on the global level. Brazil's pharmaceutical business is now positioned as the sixth in the world and is projected to be in the top five, by end of 2022.
  • Similarly, Mexico is globally positioned on 11th rank, on the list of countries in the pharmaceutical market. On the other hand, Argentina is considered the third-largest market in the region. These countries with the promising future of the pharmaceutical industry present a high opportunity for ampoules.
  • Moreover, Latin America's geriatric base is increasing rapidly. In 2010, 10% of the region's population was above 60 years, and by the end of 2040, this number is estimated to more than double, reaching 21%, according to Pharmaphorum. With this increasing aging population, chronic diseases are principally driven, because over 80% of adults aged over 60 years have at least one chronic disease.

Competitive Landscape

The ampoules packaging market is fragmented. The surge in government initiatives, and increasing demand for injectables and other medicines, provide lucrative opportunities in the ampoules packaging market. Overall, the competitive rivalry among existing competitors is high. Moving forward, expansion and mergers of large companies in different pharmaceutical industries are expected to increase the demand of ampoules packaging. Key players are Schott AG, Amposan SA, Gerresheimer AG, etc.

  • August 2021 - Serum Institute of India, the largest vaccine producer and manufacturer of biologics, had bought a 50% stake in the Indian packaging joint venture SCHOTT Kaisha. The joint venture between Germany's specialty glass company SCHOTT AG and Indian group Kaisha, manufactures pharma packaging products such as vials, syringes, ampoules and cartridges used to package life-saving medications.
  • May 2021 - Japan-based packaging company Nipro PharmaPackaging had acquired Croatian glass pharmaceutical packaging manufacturer Piramida. Under the ownership of Blue Sea Capital private equity fund, Piramida got a modernisation of its facilities, welcomed eight new production lines, and witnessed a strong development of its ampoules and vials business. This led the company being ranked among the top five largest ampoule manufacturers for the pharmaceutical industry in the European market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Force Analysis
    • 4.2.1 Threat of New Entrants
    • 4.2.2 Bargaining Power of Buyers/Consumers
    • 4.2.3 Bargaining Power of Suppliers
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Market Drivers
    • 4.3.1 Demand for Tamper-proof Pharmaceutical Product Packaging
    • 4.3.2 Commodity Value of Glass Increased with Recyclability
    • 4.3.3 Government Regulations and Standards
  • 4.4 Market Restraints
    • 4.4.1 Concerns Regarding Dumping of Used Ampoules
  • 4.5 Impact of the COVID-19 on the Ampoules Packaging Market

5 MARKET DYNAMICS

  • 5.1 Introduction to Market Drivers and Restraints
  • 5.2 Market Drivers
    • 5.2.1 Demand for Tamper-proof Pharmaceutical Product Packaging
    • 5.2.2 Government Regulations and Standards
  • 5.3 Market Restraints
    • 5.3.1 Concerns Regarding Dumping of Used Ampoules

6 MARKET SEGMENTATION

  • 6.1 By Material
    • 6.1.1 Glass
    • 6.1.2 Plastic
  • 6.2 By End-user Industry
    • 6.2.1 Pharmaceutical
    • 6.2.2 Personal Care and Cosmetic
    • 6.2.3 Other End-user Industries
  • 6.3 Geography
  • 6.4 North America
    • 6.4.1 End User
      • 6.4.1.1 Pharmaceutical
      • 6.4.1.2 Personal Care And Cosmetic
      • 6.4.1.3 Other End-user Industries
    • 6.4.2 Country
      • 6.4.2.1 United States
      • 6.4.2.2 Canada
  • 6.5 Europe
    • 6.5.1 End User
      • 6.5.1.1 Pharmaceutical
      • 6.5.1.2 Personal Care And Cosmetic
      • 6.5.1.3 Other End-user Industries
    • 6.5.2 Country
      • 6.5.2.1 United Kingdom
      • 6.5.2.2 France
      • 6.5.2.3 Germany
      • 6.5.2.4 Rest Of Europe
  • 6.6 Asia Pacific
    • 6.6.1 End User
      • 6.6.1.1 Pharmaceutical
      • 6.6.1.2 Personal Care And Cosmetic
      • 6.6.1.3 Other End-user Industries
    • 6.6.2 Country
      • 6.6.2.1 China
      • 6.6.2.2 India
      • 6.6.2.3 Japan
      • 6.6.2.4 Rest Of Asia Pacific
  • 6.7 Latin America
    • 6.7.1 End User
      • 6.7.1.1 Pharmaceutical
      • 6.7.1.2 Personal Care And Cosmetic
      • 6.7.1.3 Other End-user Industries
    • 6.7.2 Country
      • 6.7.2.1 Brazil
      • 6.7.2.2 Mexico
      • 6.7.2.3 Rest Of Latin America
  • 6.8 Middle East and Africa
    • 6.8.1 End User
      • 6.8.1.1 Pharmaceutical
      • 6.8.1.2 Personal Care And Cosmetic
      • 6.8.1.3 Other End-user Industries
    • 6.8.2 Country
      • 6.8.2.1 Saudi Arabia
      • 6.8.2.2 Egypt
      • 6.8.2.3 Rest of Middle East and Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles*
    • 7.1.1 Schott AG
    • 7.1.2 Gerresheimer AG
    • 7.1.3 Stevanato Group
    • 7.1.4 ESSCO Glass
    • 7.1.5 AAPL Solutions
    • 7.1.6 Global Pharmatech Pvt Ltd
    • 7.1.7 James Alexander Corporation
    • 7.1.8 Nipro Pharma Packaging International NV

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET